References
Bozkurt B, Ahmad T, Alexander KM, Baker WL, Bosak K, Breathett K, et al. Heart failure epidemiology and outcomes statistics: A report of the Heart Failure Society of America. J Card Fail. 2023 Oct;29(10):1412-1451. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0001
Vasan RS, Enserro DM, Beiser AS, XanthakisV. Lifetime risk of heart failure among participants in the Framingham Study. J Am Coll Cardiol.2022; 79:250-63. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0002
Pandey A, Omar W, Ayers C, LaMonte M, Klein L, Allen NB, et al. Sex and race differences in lifetime risk of heart failure with preserved ejection fraction and heart failure with reduced ejection fraction. Circulation2018; 137:1814-23. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0003
Chang PP, Wruck LM, Shahar E, Rossi JS, Loehr LR, Russell SD, et al. Trends in hospitalizations and survival of acute decompensated heart failure in four US communities (2005-2014): ARIC study community surveillance. Circulation. 2018; 138:12-24. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0004
Glynn PA, Ning H, Bavishi A, Freaney PM, Shah S, Yancy CW, et. al. Heart failure risk distribution and trends in the United States population, NHANES 1999-2016. Am J Med. 2021; 134: pp. e153-e164. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0005
Huffman MD, Berry JD, Ning H, Dyer AR, Garside DB, Cai X, et. al. Lifetime risk for heart failure among White and Black Americans: cardiovascular lifetime risk pooling project. J Am Coll Cardiol. 2013; 61: pp. 1510-1517. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0006
Khera R, Kondamudi N, Zhong L, Vaduganathan M, Parker J, Das SR, et al. Temporal trends in heart failure incidence among Medicare beneficiaries across risk factor strata, 2011 to 2016. JAMA Netw Open. 2020;3: e2022190. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0007
Tsao CW, Lyass A, Enserro D, Larson MG, Ho JE, et. al. Temporal trends in the incidence and mortality associated with heart failure with preserved and reduced ejection fraction. JACC Heart Fail. 2018; 6: pp. 678-685. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0008
Gerber Y, Weston SA, Redfield MM, Chamberlain AM, Manemann SM, Jiang R, et. al. A contemporary appraisal of the heart failure epidemic in Olmsted County, Minnesota, 2000 to 2010. JAMA Intern Med. 2015; 175: pp. 996-1004. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0009
Eberly LA, Shultz K, Merino M, Brueckner MY, Benally E, Tennison A, et al. Cardiovascular disease burden and outcomes among American Indian and Alaska Native Medicare beneficiaries. JAMA Netw Open. 2023;6(9): e2334923. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0010
Rosamond WD, Chang PP, Baggett C, Johnson A, Bertoni AG, Shahar E, et. al. Classification of heart failure in The Atherosclerosis Risk in Communities (ARIC) study: a comparison of diagnostic criteria. Circ Heart Fail. 2012; 5: pp. 152-159. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0011
Suthahar N, Lau ES, Blaha MJ, Paniagua SM, Larson MG, Psaty BM, et al. Sex-specific associations of cardiovascular risk factors and biomarkers with incident heart failure. J Am Coll Cardiol. 2020 Sep 22;76(12):1455-1465. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0012
Mohebi R, Wang D, Lau ES, Parekh JK, Allen N, Psaty BM, et al. Effect of 2022 ACC/AHA/HFSA criteria on stages of heart failure in a pooled community cohort. J Am Coll Cardiol. 2023 Jun 13;81(23):2231-2242. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0013
Centers for Disease Control and Prevention and National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES) public use data files. Accessed April 1, 2023. https://www.cdc.gov/nchs/nhanes/
Wei S, Miranda JJ, Mamas MA, Zühlke LJ, Kontopantelis E, Thabane L, et al. Sex differences in the etiology and burden of heart failure across country income level: analysis of 204 countries and territories 1990-2019. Eur Heart J Qual Care Clin Outcomes.2023 Nov 2;9(7):662-672. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0015
Piña IL, Jimenez S, Lewis EF, Morris AA, Onwuanyi A, Tam E, et al. Race and Ethnicity in Heart Failure: JACC Focus Seminar 8/9. J Am Coll Cardiol. 2021 Dec 21;78(25):2589-2598. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0016
Akwo EA, Kabagambe EK, Wang TJ, Harrell FE Jr, Blot WJ, Mumma M, et al. Heart failure incidence and mortality in the southern community cohort study. Circ Heart Fail. 2017 Mar;10(3): e003553. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0017
Heidenreich PA, Albert NM, Allen LA, Bluemke DA, Butler J, Fonarow GC, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association . Circ Heart Fail.2013; 6:606–19. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0018
Joynt Maddox KE, Elkind MSV, Aparicio HJ, Commodore-Mensah Y, de Ferranti SD, Dowd WN, et al. Forecasting the burden of cardiovascular disease and stroke in the United States through 2050-prevalence of risk factors and disease: A presidential advisory from the American Heart Association. Circulation. 2024 Jun 4. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0019
Van Nuys KE, Xie Z, Tysinger B, Hlatky MA, Goldman DP. Innovation in heart failure treatment: life expectancy, disability, and health disparities. JACC Heart Fail 2018; 6:401–9. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0020
Siontis GC, Bhatt DL, Patel CJ. Secular trends in prevalence of heart failure diagnosis over 20 years (from the US NHANES). Am J Cardiol 2022; 172: pp. 161-164. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0021
Martin SS, Aday AW, Almarzooq ZI, Anderson CAM, Arora P, Avery CL, et al. 2024 Heart disease and stroke statistics: a report of us and global data from the American Heart Association. Circulation. 2024 Feb 20;149(8): e347-e913. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0022
Lippi G and Sanchis-Gomar F. Global epidemiology and future trends of heart failure. AME Medical Journal. 2020;5. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0023
Rethy L, Petito LC, Vu THT, Kershaw K, Mehta R, Shah NS, et al. Trends in the prevalence of self-reported heart failure by race/ethnicity and age from 2001 to 2016. JAMA Cardiol. 2020; 5:1425-1429. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0024
Khera R, Pandey A, Ayers CR, et al. Contemporary epidemiology of heart failure in fee-for-service Medicare beneficiaries across healthcare settings. Circ Heart Fail. 2017 Nov;10(11): e004402. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0025
Centers for Disease Control and Prevention National Center for Health Statistics. National Health and Nutrition Examination Survey (NHANES) public-use data files. Accessed October 24th, 2022. https://www.cdc.gov/nchs/nhanes/
Stierman B, Afful J, Carroll M, Chen TC, Davy O, Fink S, et al. National health and nutrition examination survey 2017–march 2020 pre pandemic data files development of files and prevalence estimates for selected health outcomes. Available:
https://www.cdc.gov/nchs/data/nhsr/nhsr158-508.pdf . Accessed: June 23, 2024.
Global Burden of Cardiovascular Diseases Collaboration; Roth GA, Johnson CO, Abate KH, Abd-Allah F, Ahmed M, et al. The burden of cardiovascular diseases among US states, 1990-2016. JAMA Cardiol. 2018 May 1;3(5):375-389. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0028
Afzal A, van Zyl J, Nisar T, Kluger AY, Jamil AK, Felius J, et al. Trends in hospital admissions for systolic and diastolic heart failure in the United States between 2004 and 2017. Am J Cardiol. 2022 May 15; 171:99-104. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0029
Powell-Wiley TM, Baumer Y, Baah FO, Baez AS, Farmer N, Mahlobo CT, et al. Social determinants of cardiovascular disease. Circ Res. 2022; 130:782–99. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0030
Sistrunk C, Tolbert N, Sanchez-Pino MD, et al. Impact of Federal, State, and Local housing policies on disparities in cardiovascular disease in Black/African American Men and Women: from policy to pathways to biology. Front Cardiovasc Med. 2022 Apr 18; 9:756734. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0031
Bozkurt B, Coats AJS, Tsutsui H, Abdelhamid CM, Adamopoulos S, Albert N, et al. Universal definition and classification of heart failure: a report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the Universal Definition of Heart Failure: Endorsed by the Canadian Heart Failure Society, Heart Failure Association of India, Cardiac Society of Australia and New Zealand, and Chinese Heart Failure Association. Eur J Heart Fail. 2021 Mar;23(3):352-380. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0032
Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun JJ, Colvin MM, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation.2022;145:e895-e1032.
Bozkurt B. It is time to screen for heart failure: Why and how? JACC Heart Fail. 2022 Aug;10(8):598-600. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0034
Gidding SS, Lloyd-Jones D, Lima J, Ambale-Venkatesh B, et al. Prevalence of American Heart Association heart failure stages in Black and White young and middle-aged adults: The CARDIA Study. Circ Heart Fail. 2019 Sep;12(9): e005730. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0035
Xanthakis V, Enserro DM, Larson MG, Wollert KC, Januzzi JL, Levy D, et al. Prevalence, neurohormonal correlates, and prognosis of heart failure stages in the community. JACC Heart Fail. 2016 Oct;4(10):808-815. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0036
Ammar KA, Jacobsen SJ, Mahoney DW, Kors JA, Redfield MM, Burnett JC, et al. Prevalence and prognostic significance of heart failure stages: application of the American College of Cardiology/American Heart Association Heart Failure Staging Criteria in The Community. Circulation. 2007; 115:1563-70. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0037
Dunlay SM, Roger VL, Killian JM, Weston SA, Schulte PJ, Subramaniam AV, et al. Advanced heart failure epidemiology and outcomes: A population-based study. JACC Heart Fail. Oct 2021;9(10):722-732. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0038
Roger VL, Banaag A, Korona-Bailey J, et al. Prevalence of heart failure stages in a universal health care system: the military health system experience. Am J Med. 2023;136(11):1079-1086 e1071. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0039
Shah AM, Claggett B, Loehr LR, Chang PP, Matsushita K, Kitzman D, et al. Heart failure stages among older adults in the community: the atherosclerosis risk in communities study. Circulation. 2017 Jan 17;135(3):224-240. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0040
Jia X, Al Rifai M, Ndumele CE, Virani SS, de Lemos JA, Lee E, et al. Reclassification of pre-heart failure stages using cardiac biomarkers: The ARIC Study. JACC Heart Fail. 2023 Apr;11(4):440-450. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0041
Vasan RS, Musani SK, Matsushita K, Beard W, Obafemi OB, Butler KR, et al. Epidemiology of heart failure stages in middle-aged black people in the community: prevalence and prognosis in the atherosclerosis risk in communities study. J Am Heart Assoc. 2021 May 4;10(9):e016524. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0042
Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA. The global burden of cardiovascular diseases and risk: A compass for future health. J Am Coll Cardiol.2022 Dec 20;80(25):2361-2371. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0043
Conrad N, Judge A, Tran J, Mohseni H, Hedgecott D, Crespillo AP, et al. Temporal trends and patterns in heart failure incidence: a population-based study of 4 million individuals. Lancet. 2018 Feb 10;391(10120):572-580. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0044
Kovell LC, Juraschek SP, Russell SD. Stage a heart failure is not adequately recognized in us adults: analysis of the national health and nutrition examination surveys, 2007-2010. PLoS One. 2015 Jul 14;10(7):e0132228. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0045
Breathett K, Leng I, Foraker RE, Abraham WT, Coker L, Whitfield KE, et al. Risk factor burden, heart failure, and survival in women of different ethnic groups: insights from the women’s health initiative. Circ Heart Fail. 2018 May;11(5): e004642. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0046
Dunlay SM, Weston SA, Jacobsen SJ, Roger VL. Risk factors for heart failure: a population-based case-control study. Am J Med. 2009 Nov;122(11):1023-8. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0047
Yeh RW, Sidney S, Chandra M, Sorel M, Selby JV, Go AS. Population trends in the incidence and outcomes of acute myocardial infarction. N Engl J Med. 2010 Jun 10;362(23):2155-65. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0048
Gerber Y, Weston SA, Enriquez-Sarano M, Manemann SM, Chamberlain AM, Jiang R, et al. Atherosclerotic burden and heart failure after myocardial infarction. JAMA Cardiol. 2016 May 1;1(2):156-62. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0049
Eaton CB, Pettinger M, Rossouw J, Martin LW, Foraker R, Quddus A, et al. Risk factors for incident hospitalized heart failure with preserved versus reduced ejection fraction in a multiracial cohort of postmenopausal women. Circ Heart Fail. 2016;9:e002883. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0050
Cheng S, Claggett B, Correia AW, Shah AM, Gupta DK, Skali H, et al. Temporal trends in the population attributable risk for cardiovascular disease: the Atherosclerosis Risk in Communities Study. Circulation. 2014 Sep 2;130(10):820-8. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0051
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). Oct 17 2020;396(10258):1204-1222. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0052
Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats A. Global burden of heart failure: A comprehensive and updated review of epidemiology. Cardiovasc Res. 2023 Jun 13;119(6):1453. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0053
Shahim B, Kapelios CJ, Savarese G, Lund LH. Global public health burden of heart failure: An updated review. Card Fail Rev. 2023;9:e11. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0054
Bellanca L, Linden S, Farmer R. Incidence and prevalence of heart failure in England: a descriptive analysis of linked primary and secondary care data – the PULSE study. BMC Cardiovasc Disord. 2023 Jul 26;23(1):374. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0055
Ruiz-García A, Serrano-Cumplido A, Escobar-Cervantes C, Arranz-Martínez E, Turégano-Yedro M, Pallarés-Carratalá V. Heart failure prevalence rates and its association with other cardiovascular diseases and chronic kidney disease: SIMETAP-HF study. J Clin Med. 2023 Jul 26;12(15):4924. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0056
Emmons-Bell S, Johnson C, Roth G. Prevalence, incidence and survival of heart failure: a systematic review . Heart. Aug 11 2022;108(17):1351-1360. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0057
Groenewegen A, Rutten FH, Mosterd A, Hoes AW. Epidemiology of heart failure. Eur J Heart Fail.2020 Aug;22(8):1342-1356. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0058
Elasfar AA, Alhabeeb W, Elasfar S. Heart failure in the Middle East Arab Countries: Current and future perspectives. J Saudi Heart Assoc. 2020;32(2):236-241. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0059
Agbor VN, Essouma M, Ntusi NAB, Nyaga UF, Bigna JJ, Noubiap JJ. Heart failure in sub-Saharan Africa: A contemporaneous systematic review and meta-analysis. Int J Cardiol. Apr 15 2018;257:207-215. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0060
Christiansen MN, Køber L, Weeke P, Vasan RS, Jeppesen JL, Smith JG,, et al. Age-specific trends in incidence, mortality, and comorbidities of heart failure in Denmark, 1995 to 2012. Circulation. Mar 28 2017;135(13):1214-1223. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0061
Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, et al. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry. Eur J Heart Fail.2017 Dec;19(12):1574-1585. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0062
Joseph P, Dokainish H, McCready T, Budaj A, Roy A, Ertl G, et al. A multinational registry to study the characteristics and outcomes of heart failure patients: The global congestive heart failure (G-CHF) registry. Am Heart J. 2020 Sep; 227:56-63. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0063
MacDonald MR, Tay WT, Teng TK, Anand I, Ling LH, Yap J, et al. Regional variation of mortality in heart failure with reduced and preserved ejection fraction across Asia: outcomes in the ASIAN-HF Registry. J Am Heart Assoc. 2020 Jan 7;9(1):e012199. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0064
Shiga T, Suzuki A, Haruta S, Mori F, Ota Y, Yagi M, et al. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. ESC Heart Fail. Jun 2019;6(3):475-486. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0065
Karaye KM, Dokainish H, ElSayed A, Mondo C, Damasceno A, Sliwa K, et al. Clinical Profiles and Outcomes of Heart Failure in Five African Countries: Results from INTER-CHF Study. Glob Heart. 2021;16(1):50. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0066
Wang H, Li Y, Chai K, Long Z, Yang Z, Du M, Wang S, et al. Mortality in patients admitted to hospital with heart failure in China: a nationwide Cardiovascular Association Database-Heart Failure Centre Registry cohort study. Lancet Glob Health. Apr 2024;12(4): e611-e622. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0067
Wang N, Hales S, Barin E, Tofler G. Characteristics and outcome for heart failure patients with mid-range ejection fraction. J Cardiovasc Med (Hagerstown).2018 Jun;19(6):297-303. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0068
Kingery JR, Roberts NL, Lookens Pierre J, Sufra R, Dade E, Rouzier V, et al. Population-Based Epidemiology of Heart Failure in a Low-Income Country: The Haiti Cardiovascular Disease Cohort. Circ Cardiovasc Qual Outcomes. 2023 Feb;16(2):e009093. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0069
Ho JE, Enserro D, Brouwers FP, Kizer JR, Shah SJ, Psaty BM, et al. Predicting heart failure with preserved and reduced ejection fraction: the international collaboration on heart failure subtypes. Circ Heart Fail.2016 Jun;9(6):10.1161. https://doi.org/10.1161/CIRCHEARTFAILURE.115.003116
Kalogeropoulos A, Georgiopoulou V, Kritchevsky SB, Psaty BM, Smith NL, Newman AB, et al. Epidemiology of incident heart failure in a contemporary elderly cohort: the health, aging, and body composition study. Arch Intern Med. 2009 Apr 13;169(7):708-15. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0071
Khatibzadeh S, Farzadfar F, Oliver J, Ezzati M, Moran A. Worldwide risk factors for heart failure: a systematic review and pooled analysis. International journal of cardiology. Sep 30 2013;168(2):1186-94. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0072
Yan T, Zhu S, Yin X, et al. Burden, trends, and inequalities of heart failure globally, 1990 to 2019: A secondary analysis based on the global burden of disease 2019 study. J Am Heart Assoc. Mar 21 2023;12(6): e027852. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0073
Walli-Attaei M, Joseph P, Johansson I, Sliwa K, Lonn E, Maggioni AP, et al. Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive Heart Failure (G-CHF) registry. Lancet Glob Health. Mar 2024;12(3):e396-e405. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0074
Chamberlain AM, Boyd CM, Manemann SM, Dunlay SM, Gerber Y, Killian JM, et al. Risk factors for heart failure in the community: differences by age and ejection fraction. Am J Med. 2020 Jun;133(6):e237-e248. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0075
Feng J, Zhang Y, Zhang J. Epidemiology and burden of heart failure in Asia. JACC Asia. Apr 2024;4(4):249-264. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0076
Jia Y, Lin Z, He Z, Li C, Zhang Y, Wang J, et al. Effect of air pollution on heart failure: systematic review and meta-analysis. Environ Health Perspect. 2023 Jul;131(7):76001. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0077
Center for Disease Control and Prevention. Wide-ranging ONline Data for Epidemiologic Research Database. Accessed: June 22, 2024. https://wonder.cdc.gov .
Sayed A, Abramov D, Fonarow GC, Mamas MA, Kobo O, Butler J, et al. Reversals in the decline of heart failure mortality in the US, 1999 to 2021. JAMA Cardiol. 2024 Jun 1;9(6):585-589. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0079
Keshvani N, Mehta A, Alger HM, et al. Heart failure quality of care and in-hospital outcomes during the COVID-19 pandemic: findings from the Get With The Guidelines-Heart Failure registry. Eur J Heart Fail. Jun 2022;24(6):1117-1128. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0080
Greene SJ, Lautsch D, Yang L, Tan XI, Brady JE. Prognostic Interplay Between COVID-19 and heart failure with reduced ejection fraction. J Card Fail.Aug 2022;28(8):1287-1297. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0081
Kittipibul V, Vaduganathan M, Ikeaba U, Chiswell K, Butler J, DeVore AD, et al. Cause-specific healthcare costs following hospitalization for heart failure and cost offset with SGLT2 inhibitor therapy. JACC Heart Fail.2024 Apr 6: S2213-1779(24)00268-3. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0082
Diamond J, Ayodele I, Fonarow GC, Joynt-Maddox KE, Yeh RW, Hammond G, et al. Quality of care and clinical outcomes for patients with heart failure at hospitals caring for a high proportion of Black adults: Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. Jun 1 2023;8(6):545-553. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0083
Foroutan F, Rayner DG, Ross HJ, Ehler T, Srivastava A, Shin S, et al. Global comparison of readmission rates for patients with heart failure. J Am Coll Cardiol. 2023 Aug 1;82(5):430-444. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0084
Setoguchi S, Stevenson LW, Schneeweiss S. Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J.2007; 154: 260-266. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0085
Lee DS, Austin PC, Stukel TA, Alter DA, Chong A, Parker JD, et al. “Dose-dependent” impact of recurrent cardiac events on mortality in patients with heart failure. Am J Med. 2009 Feb;122(2):162-169.e1. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0086
Pierce JB, Shah NS, Petito LC, Pool L, Lloyd-Jones DM, Feinglass J, Khan SS. Trends in heart failure-related cardiovascular mortality in rural versus urban United States counties, 2011-2018: A cross-sectional study. PLoS One. 2021 Mar 3;16(3):e0246813. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0087
Bozkurt B. Concerning Trends of Rising Heart Failure Mortality Rates. JACC Heart Fail.2024 May;12(5):970-972. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0088
Glynn P, Lloyd-Jones DM, Feinstein MJ, Carnethon M, Khan SS. Disparities in cardiovascular mortality related to heart failure in the United States. J Am Coll Cardiol. 2019 May 14;73(18):2354-2355. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0089
Keshvani N, Shah S, Ayodele I, Chiswell K, Alhanti B, Allen LA, et al. Sex differences in long-term outcomes following acute heart failure hospitalization: Findings from the Get with the guidelines-heart failure registry. Eur J Heart Fail. 2023 Sep;25(9):1544-1554. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0090
DeFilippis EM, Masotti M, Blumer V, Maharaj V, Cogswell R. Sex-specific outcomes of candidates listed as the highest priority status for heart transplantation. Circ Heart Fail. 2023 Jun;16(6):e009946. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0091
Anon. Provisional Mortality Statistics, 2018 through Last Week Results Form Accessed May 29, 2024. https://wonder.cdc.gov/controller/datarequest/D176;jsessionid=6B88391EA41D7E13132C5D940043
Paglino E, Lundberg DJ, Wrigley-Field E, Zhou Z, Wasserman JA, Raquib R, et al. Excess natural-cause mortality in US counties and its association with reported COVID-19 deaths. Proc Natl Acad Sci U S A. 2024 Feb 6;121(6):e2313661121. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0093
Breathett K, Knapp SM, Carnes M, Calhoun E, Sweitzer NK. Imbalance in heart transplant to heart failure mortality ratio among African American, Hispanic, and White patients. Circulation. 2021; 143:2412–2414. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0094
Chouairi F, Fuery M, Clark KA, Mullan CW, Stewart J, Caraballo C,, et al. Evaluation of racial and ethnic disparities in cardiac transplantation. J Am Heart Assoc. 2021;10: e021067. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0095
American Hospital Association Rural Report: Challenges Facing Rural Communities and the Roadmap to Ensure Local Access to High-quality, Affordable Care. Accessed March 24, 2024. https://www.aha.org/system/files/2019-02/rural-report-2019.pdf
Brandt EJ, Tobb K, Cambron JC, Ferdinand K, Douglass P, Nguyen PK, et al. Assessing and addressing social determinants of cardiovascular health: JACC state-of-the-art review. J Am Coll Cardiol. 2023;81(14):1368-1385. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0097
Jain V, Minhas AMK, Morris AA, Greene SJ, Pandey A, Khan SS, et al. Demographic and regional trends of heart failure-related mortality in young adults in the US, 1999-2019. JAMA Cardiol. Sep 1 2022;7(9):900-904. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0098
Glynn PA, Molsberry R, Harrington K, Shah NS, Petito LC, Yancy CW, et al. Geographic variation in trends and disparities in heart failure mortality in the United States, 1999 to 2017. J Am Heart Assoc. 2021 May 4;10(9):e020541. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0099
Yu B, Akushevich I, Yashkin AP, Yashin AI, Lyerly HK, Kravchenko J. Epidemiology of geographic disparities in heart failure among US older adults: a Medicare-based analysis. BMC public health. Jul 1 2022;22(1):1280. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0100
Centers for Disease Control and Prevention. Heart Failure. Accessed: June 25, 2024. https://www.cdc.gov/heartdisease/heart_failure.htm
Mohebi R, Chen C, Ibrahim NE, McCarthy CP, Gaggin HK, et al. Cardiovascular disease projections in the United States based on the 2020 census estimates. J Am Coll Cardiol. 2022 Aug 9;80(6):565-578. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0102
White-Williams C, Rossi LP, Bittner VA, Driscoll A, Durant RW, Granger BB, et al. Addressing social determinants of health in the care of patients with heart failure: a scientific statement from the American Heart Association. Circulation. Jun 2 2020;141(22): e841-e863. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0103
Vinter N, Fawzy AM, Gent D, Ding WY, Johnsen SP, Frost L, et al. Social determinants of health and cardiovascular outcomes in patients with heart failure. Eur J Clin Invest. Nov 2022;52(11): e13843. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0104
Shirey TE, Hu Y, Ko YA, Nayak A, Udeshi E, Patel S, et al. Relation of neighborhood disadvantage to heart failure symptoms and hospitalizations. Am J Cardiol. 2021 Feb 1; 140:83-90. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0105
Mujahid MS, Gao X, Tabb LP, Morris C, Lewis TT. Historical redlining and cardiovascular health: The multi-ethnic study of atherosclerosis. Proc Natl Acad Sci U S A. 2021 Dec 21;118(51):e2110986118. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0106
Shah KS, Xu H, Matsouaka RA, Bhatt DL, Heidenreich PA, Hernandez AF, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol 2017; 70:2476–86. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0107
Tsao CW, Lyass A, Enserro D, Larson MG, Ho JE, et al. Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction. JACC Heart Fail. 2018 Aug;6(8):678-685. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0108
Lam CSP, Gamble GD, Ling LH, Sim D, Leong KTG, et al. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study. Eur Heart J. 2018 May 21;39(20):1770-1780. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0109
Savarese G, Stolfo D, Sinagra G, Lund LH. Heart failure with mid-range or mildly reduced ejection fraction. Nat Rev Cardiol. 2022 Feb;19(2):100-116. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0110
Dimond MG, Ibrahim NE, Fiuzat M, McMurray JJV, Lindenfeld J, Ahmad T, et al. Left ventricular ejection fraction and the future of heart failure phenotyping. JACC Heart Fail. 2024 Mar;12(3):451-460. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0111
Florea VG, Rector TS, Anand IS, Cohn JN. Heart failure with improved ejection fraction: clinical characteristics, correlates of recovery, and survival: Results from the valsartan heart failure trial. Circ Heart Fail. 2016 Jul;9(7):e003123. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0112
Vardeny O, Desai AS, Jhund PS, Fang JC, Claggett B, de Boer RA, et al. Dapagliflozin and mode of death in heart failure with improved ejection fraction: A post hoc analysis of the DELIVER trial. JAMA Cardiol. 2024 Mar 1;9(3):283-289. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0113
Jones NR, Roalfe AK, Adoki I, Hobbs FDR, Taylor CJ. Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis. Eur J Heart Fail. Nov 2019;21(11):1306-1325. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0114
GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov 10;392(10159):1789-1858.
G-CHF Investigators; Joseph P, Roy A, Lonn E, Störk S, Floras J, et al. Global variations in heart failure etiology, management, and outcomes. JAMA. May 16 2023;329(19):1650-1661. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0116
Isath A, Malik A, Bandyopadhyay D, Goel A, Hajra A, Dhand A, et al. COVID-19, Heart Failure Hospitalizations, and Outcomes: A Nationwide Analysis. Curr Probl Cardiol. 2023 Apr;48(4):101541. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0117
Bhatt AS, Jering KS, Vaduganathan M, Claggett BL, Cunningham JW, Rosenthal N, et al. Clinical outcomes in patients with heart failure hospitalized with COVID-19. JACC Heart Fail. 2021 Jan;9(1):65-73. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0118
Salah HM, Minhas AMK, Khan MS, Khan SU, Ambrosy AP, Blumer V, et al. Trends and characteristics of hospitalizations for heart failure in the United States from 2004 to 2018. ESC Heart Fail. 2022; 9:947-952. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0119
Agarwal MA, Fonarow GC, Ziaeian B. National trends in heart failure hospitalizations and readmissions from 2010 to 2021. [In Press].
Khan MS, Sreenivasan J, Lateef N, Abougergi MS, Greene SJ, Ahmad T, Anker SD, Fonarow GC, Butler J. Trends in 30- and 90-day readmission rates for heart failure. Circ Heart Fail. 2021 Apr;14(4):e008335. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0121
Salah HM, Minhas AMK, Khan MS, Khan SU, Ambrosy AP, Blumer V, et al. Trends in hospitalizations for heart failure, acute myocardial infarction, and stroke in the United States from 2004 to 2018. Am Heart J. 2022; 243:103-109. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0122
Clark KAA, Reinhardt SW, Chouairi F, Miller PE, Kay B, Fuery M, et al. Trends in heart failure hospitalizations in the US from 2008 to 2018. J Card Fail. 2022; 28:171-180. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0123
Minhas AMK, Ijaz SH, Jamal S, Dani SS, Khan MS, Greene SJ, ey al. Trends in characteristics and outcomes in primary heart failure hospitalizations among older population in the United States, 2004 to 2018. Circ Heart Fail. 2022;15:e008943. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0124
Elbadawi A, Dang A, Elgendy IY, Thakker R, Albaeni A, Omer MA, et al. Age-specific trends and outcomes of hospitalizations with acute heart failure in the United States. Int J Cardiol. 2021; 330:98-105. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0125
Hamo CE, Fonarow GC, Greene SJ, Vaduganathan M, Yancy CW, Heidenreich P, et al. Temporal trends in risk profiles among patients hospitalized for heart failure. Am Heart J.2021; 232:154-163. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0126
Ziaeian B, Kominski GF, Ong MK, Mays VM, Brook RH, Fonarow GC. National differences in trends for heart failure hospitalizations by sex and race/ethnicity. Circ Cardiovasc Qual Outcomes. 2017 Jul;10(7):e003552. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0127
Anon. Interactive Atlas of Heart Disease and Stroke Tables Accessed May 29, 2024. https://nccd.cdc.gov/DHDSPAtlas/reports.aspx?geographyTpe=county&state=KY&themeId=15&filterIds=1,5,3,6,7&filterOptions=1,1,1,1,1
Lewsey SC, Breathett K. Racial and ethnic disparities in heart failure: current state and future directions. Curr Opin Cardiol. 2021; 36:320-328. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0129
Breathett K, Lewsey S, Brownell NK, Enright K, Evangelista LS, Ibrahim NE,, et al. Implementation Science to Achieve Equity in Heart Failure Care: A scientific statement from the American Heart Association. Circulation.2024;149: e1143–e1163. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0130
Maddox TM, Januzzi JL Jr, Allen LA, Breathett K, Brouse S, Butler J, et al. 2024 ACC expert consensus decision pathway for treatment of heart failure with reduced ejection fraction: A report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2024; 83:1444–1488. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0131
Vaduganathan M, Claggett BL, Greene SJ, Aggarwal R, Bhatt AS, McMurray JJV,, et al. potential implications of expanded US Food and Drug Administration labeling for sacubitril/valsartan in the US. JAMA Cardiol. Dec 1 2021;6(12):1415-1423. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0132
Pierce JB, Ikeaba U, Peters AE, DeVore AD, Chiswell K, Allen LA, et al. Quality of care and outcomes among patients hospitalized for heart failure in rural vs urban us hospitals: The Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. Apr 1 2023;8(4):376-385. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0133
Arundel C, Lam PH, Gill GS, et al. Systolic blood pressure and outcomes in patients with heart failure with reduced ejection fraction. J Am Coll Cardiol. Jun 25 2019;73(24):3054-3063. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0134
Tsimploulis A, Lam PH, Arundel C, et al. Systolic blood pressure and outcomes in patients with heart failure with preserved ejection fraction. JAMA Cardiol. Apr 1 2018;3(4):288-297. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0135
Stolfo D, Lund LH, Benson L, Hage C, Sinagra G, Dahlström U, et al. Persistent high burden of heart failure across the ejection fraction spectrum in a nationwide setting. J Am Heart Assoc. Nov 15 2022;11(22):e026708. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0136
Canepa M, Kapelios CJ, Benson L, Savarese G, Lund LH. Temporal trends of heart failure hospitalizations in cardiology versus noncardiology wards according to ejection fraction: 16-year data from the SwedeHF registry. Circ Heart Fail. Aug 2022;15(8): e009462. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0137
Greene SJ, Ayodele I, Pierce JB, Khan MS, Lewsey SC, Yancy CW, et al. Eligibility and projected benefits of rapid initiation of quadruple medical therapy for newly diagnosed heart failure. JACC Heart Fail. 2024 Mar 25: S2213-1779(24)00244-0. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0138
Sumarsono A, Xie L, Keshvani N, Zhang C, Patel L, Alonso WW, et al. Sex disparities in longitudinal use and intensification of guideline-directed medical therapy among patients with newly diagnosed heart failure with reduced ejection fraction. Circulation. 2024; 149:510-520. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0139
Bozkurt B, Savarese G, Adamsson Eryd S, Bodegard J, Cleland JGF, et al. Mortality, outcomes, costs, and use of medicines following a first heart failure hospitalization: EVOLUTION HF. JACC Heart Fail. 2023;11:1320-1332. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0140
Writing C, Kittleson MM, Ruberg FL, Ambardekar AV, Brannagan TH, Cheng RK, et al. 2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis: A report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2023; 81:1076-1126. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0141
Bozkurt B. Contemporary pharmacological treatment and management of heart failure. Nat Rev Cardiol.2024 Mar 26. https://doi.org/10.1038/s41569-024-00997-0 Epub ahead of print.
Arnold SV, Silverman DN, Gosch K, Nassif ME, Infeld M, Litwin S, et al. Beta-blocker use and heart failure outcomes in mildly reduced and preserved ejection fraction. JACC Heart Fail. 2023; 11:893-900. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0143
Peikert A, Bart BA, Vaduganathan M, Claggett BL, Kulac IJ, Kosiborod MN, et al. Contemporary use and implications of beta-blockers in patients with HFmrEF or HFpEF: The DELIVER Trial. JACC Heart Fail. 2024;12:631-644. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0144
Mentz RJ, Ward JH, Hernandez AF, Lepage S, Morrow DA, Sarwat S, et al. Angiotensin-neprilysin inhibition in patients with mildly reduced or preserved ejection fraction and worsening heart failure. J Am Coll Cardiol. 2023; 82:1-12. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0145
Foa A, Vaduganathan M, Claggett BL, Pabon MA, Lu H, Pfeffer MA, et al. Sacubitril/valsartan-related hypotension in patients with heart failure and preserved or mildly reduced ejection fraction. J Am Coll Cardiol. 2024;83:1731-1739. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0146
Data from Scientific Registry of Transplant Recipients (SRTR)
Kittleson MM, Sharma K, Brennan DC, Cheng XS, Chow SL, Colvin M, et al. Dual-organ transplantation: indications, evaluation, and outcomes for heart-kidney and heart-liver transplantation: A scientific statement from the American Heart Association. Circulation. 2023; 148:622-636. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0148
United Network for Organ Sharing. Accessed: June 23, 2024. https://unos.org/data/
Jorde UP, Saeed O, Koehl D, Morris AA, Wood KL, Meyer DM, et al. The Society of Thoracic Surgeons Intermacs 2023 annual report: focus on magnetically levitated devices. Ann Thorac Surg. 2024; 117:33-44. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0150
Mullan CW, Chouairi F, Sen S, Mori M, Clark KAA, Reinhardt SW, et al. Changes in use of left ventricular assist devices as bridge to transplantation with new heart allocation policy. JACC Heart Fail. 2021 Jun;9(6):420-429. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0151
Kazi DS, Elkind MSV, Deutsch A, Dowd WN, Heidenreich P, Khavjou O, et al. Forecasting the economic burden of cardiovascular disease and stroke in the United States through 2050: A presidential advisory from the American Heart Association. Circulation. 2024 Jun 4. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0152
Bhatnagar R, Fonarow GC, Heidenreich PA, Ziaeian B. Expenditure on heart failure in the United States: The medical expenditure panel survey 2009-2018. JACC Heart Fail. 2022 Aug;10(8):571-580. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0153
Kittipibul V, Vaduganathan M, Ikeaba U, Chiswell K, Butler J, DeVore AD, et al. Cause-specific health care costs following hospitalization for heart failure and cost offset With SGLT2i Therapy. JACC Heart Fail. 2024 Apr 6: S2213-1779(24)00268-3. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0154
Camplain R, Kucharska-Newton A, Loehr L, Keyserling TC, Layton JB, Wruck L, et al. Accuracy of self-reported heart failure. The Atherosclerosis Risk in Communities (ARIC) Study. J Card Fail. 2017 Nov;23(11):802-808. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0155
Ziaeian B, Fonarow GC. Making heart failure count. Eur J Heart Fail. 2021 Jun;23(6):917-918. http://refhub.elsevier.com/S1071-9164(24)00232-X/sbref0156